A Dose Reduction Immunobridging and Safety Study of Two HPV Vaccines in Tanzanian Girls

NCT02834637 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

930

Enrollment

OTHER

Sponsor class

Conditions

Human Papilloma Virus

Interventions

DRUG: bivalent HPV vaccine
DRUG: nonavalent HPV vaccine

Sponsor

London School of Hygiene and Tropical Medicine

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]